US Patent Issued to ZHEJIANG LAB on Aug. 5 for "Pancreatic postoperative diabetes prediction system based on supervised deep subspace learning" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,381,007, issued on Aug. 5, was assigned to ZHEJIANG LAB (Hangzhou, China).

"Pancreatic postoperative diabetes prediction system based on supervised deep subspace learning" was invented by Jingsong Li (Hangzhou, China), Peijun Hu (Hangzhou, China), Yu Tian (Hangzhou, China) and Tianshu Zhou (Hangzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A pancreatic postoperative diabetes prediction system based on supervised deep subspace learning. A deep convolutional neural network and the MITK software are used to obtain postoperative residual pancreas area, so as to taken as the region-of-interest. Traditional image radiomics features and deep semant...